⌘K

Login Start Free

Home/Filings/4/0001562180-19-005991

4//SEC Filing

Robichaud Albert 4

Accession 0001562180-19-005991

CIK 0001597553other

View on SEC.gov Company Profile

Filed

Dec 9, 7:00 PM ET

Accepted

Dec 10, 8:04 PM ET

Size

18.8 KB

Accession

0001562180-19-005991

Insider Transaction Report

Form 4

Period: 2019-12-09

Sage Therapeutics, Inc.SAGE

Robichaud Albert

Chief Scientific Officer

Transactions

Exercise/Conversion
Common Stock
2019-12-09$38.25/sh+5,732$219,249→ 108,324 total
Exercise/Conversion
Common Stock
2019-12-09$28.63/sh+3,076$88,066→ 111,400 total
Exercise/Conversion
Stock Option (Right to Buy)
2019-12-09−3,076→ 21,924 total
Exercise: $28.63Exp: 2026-02-08→ Common Stock (3,076 underlying)
Purchase
Common Stock
2019-12-09$64.16/sh+25,000$1,604,000→ 136,400 total
Exercise/Conversion
Stock Option (Right to Buy)
2019-12-09−5,732→ 32,668 total
Exercise: $38.25Exp: 2025-01-23→ Common Stock (5,732 underlying)
Exercise/Conversion
Common Stock
2019-12-09$1.36/sh+6,935$9,432→ 102,592 total
Exercise/Conversion
Stock Option (Right to Buy)
2019-12-09−6,935→ 0 total
Exercise: $1.36Exp: 2024-01-24→ Common Stock (6,935 underlying)

Footnotes (4)

[F1]This transaction was executed in multiple trades at prices ranging from $63.77 USD to $64.25 USD. The price reported above reflects the weighted average sale price. The issuer hereby undertakes to provide, upon request, to the SEC staff or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
[F2]The stock option award was issued pursuant to the Sage Therapeutics, Inc. 2011 Stock Option and Incentive Plan. The option vested in full on January 1, 2018.
[F3]The stock option award was issued pursuant to the Sage Therapeutics, Inc. 2014 Stock Option and Incentive Plan. The option vested in full on January 23, 2019.
[F4]The securities awarded on 2/08/2016 were in the form of stock options issued pursuant to the Sage Therapeutics, Inc. 2014 Stock Option and Incentive Plan. Options to purchase 6,250 shares of common stock vested on the one year anniversary of the vesting start date with 18,750 shares vesting in 36 equal monthly installments thereafter.

Documents

2 files

Issuer

Sage Therapeutics, Inc.

CIK 0001597553

Entity typeother

Related Parties

1

filerCIK 0001612861

Filing Metadata

Form type: 4
Filed: Dec 9, 7:00 PM ET
Accepted: Dec 10, 8:04 PM ET
Size: 18.8 KB

View on SEC.gov